BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8934050)

  • 1. Final results of the Royal College of Radiologists' trial comparing two different radiotherapy schedules in the treatment of cerebral metastases.
    Priestman TJ; Dunn J; Brada M; Rampling R; Baker PG
    Clin Oncol (R Coll Radiol); 1996; 8(5):308-15. PubMed ID: 8934050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation therapy for brain metastases from lung carcinoma. Prospective randomized trial according to the level of lactate dehydrogenase.
    Chatani M; Matayoshi Y; Masaki N; Inoue T
    Strahlenther Onkol; 1994 Mar; 170(3):155-61. PubMed ID: 8160096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.
    Rades D; Lohynska R; Veninga T; Stalpers LJ; Schild SE
    Cancer; 2007 Dec; 110(11):2587-92. PubMed ID: 17893909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
    Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
    Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated radiotherapy for brain metastases.
    Nieder C; Nestle U; Niewald M; Schnabel K
    Radiother Oncol; 1997 Oct; 45(1):17-22. PubMed ID: 9364627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The radiotherapy of brain metastases in bronchial carcinoma].
    Nieder C; Niewald M; Schnabel K
    Strahlenther Onkol; 1994 Jun; 170(6):335-41. PubMed ID: 8023242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of a randomized clinical trial comparing two radiation schedules in the palliative treatment of brain metastases.
    Haie-Meder C; Pellae-Cosset B; Laplanche A; Lagrange JL; Tuchais C; Nogues C; Arriagada R
    Radiother Oncol; 1993 Feb; 26(2):111-6. PubMed ID: 7681997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of the mini-mental status examination in the treatment of patients with brain metastases: a report from the Radiation Therapy Oncology Group protocol 91-04.
    Murray KJ; Scott C; Zachariah B; Michalski JM; Demas W; Vora NL; Whitton A; Movsas B
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):59-64. PubMed ID: 10924972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).
    Rades D; Bohlen G; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Dunst J
    Strahlenther Onkol; 2007 Nov; 183(11):631-6. PubMed ID: 17960339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104.
    Murray KJ; Scott C; Greenberg HM; Emami B; Seider M; Vora NL; Olson C; Whitton A; Movsas B; Curran W
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):571-4. PubMed ID: 9336134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Final results of the Royal College of Radiologists' trial comparing two different radiotherapy schedules in the treatment of cerebral metastases.
    Jones B; Dale RG
    Clin Oncol (R Coll Radiol); 1997; 9(2):134-5. PubMed ID: 9135901
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302.
    Nelson DF; Curran WJ; Scott C; Nelson JS; Weinstein AS; Ahmad K; Constine LS; Murray K; Powlis WD; Mohiuddin M
    Int J Radiat Oncol Biol Phys; 1993 Jan; 25(2):193-207. PubMed ID: 8380567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
    Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose escalation of whole-brain radiotherapy for brain metastases from melanoma.
    Rades D; Heisterkamp C; Huttenlocher S; Bohlen G; Dunst J; Haatanen T; Schild SE
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):537-41. PubMed ID: 19733017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inoperable non-small-cell lung cancer (NSCLC): a Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions. Report to the Medical Research Council by its Lung Cancer Working Party.
    Br J Cancer; 1991 Feb; 63(2):265-70. PubMed ID: 1705140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy for cerebral metastases.
    Sneed PK; Larson DA; Wara WM
    Neurosurg Clin N Am; 1996 Jul; 7(3):505-15. PubMed ID: 8823778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life and symptoms control in brain metastasis after palliative whole brain radiotherapy using two different protocols.
    Akhtar MS; Kousar F; Fatmi S; Jabeen K; Akhtar K
    J Coll Physicians Surg Pak; 2012 May; 22(5):311-6. PubMed ID: 22538037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Rades D; Pluemer A; Veninga T; Dunst J; Schild SE
    Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palliative chemoradiotherapy versus radiotherapy alone for dysphagia in advanced oesophageal cancer: a multicentre randomised controlled trial (TROG 03.01).
    Penniment MG; De Ieso PB; Harvey JA; Stephens S; Au HJ; O'Callaghan CJ; Kneebone A; Ngan SY; Ward IG; Roy R; Smith JG; Nijjar T; Biagi JJ; Mulroy LA; Wong R;
    Lancet Gastroenterol Hepatol; 2018 Feb; 3(2):114-124. PubMed ID: 29248399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.
    Prados MD; Wara WM; Sneed PK; McDermott M; Chang SM; Rabbitt J; Page M; Malec M; Davis RL; Gutin PH; Lamborn K; Wilson CB; Phillips TL; Larson DA
    Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):71-7. PubMed ID: 11163499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.